U.S. markets open in 8 hours 57 minutes
  • S&P Futures

    3,615.50
    -21.00 (-0.58%)
     
  • Dow Futures

    29,657.00
    -217.00 (-0.73%)
     
  • Nasdaq Futures

    12,224.00
    -33.50 (-0.27%)
     
  • Russell 2000 Futures

    1,838.00
    -15.00 (-0.81%)
     
  • Crude Oil

    44.92
    -0.61 (-1.34%)
     
  • Gold

    1,770.10
    -18.00 (-1.01%)
     
  • Silver

    22.05
    -0.59 (-2.62%)
     
  • EUR/USD

    1.1973
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    0.8420
    -0.8780 (-100.00%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3337
    +0.0023 (+0.17%)
     
  • USD/JPY

    103.8690
    -0.2160 (-0.21%)
     
  • BTC-USD

    18,545.70
    +194.25 (+1.06%)
     
  • CMC Crypto 200

    365.68
    +28.18 (+8.35%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,429.62
    -215.09 (-0.81%)
     

Coloplast A/S - Transactions in connection with share buy-back programme, week 28

·2 min read

As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.

The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed during the period 6 – 10 July 2020 :

Date

Number of shares

Average purchase price, DKK

Transaction value, DKK

6 July 2020

200

1,034.72

206,944

7 July 2020

200

1,029.75

205,950

8 July 2020

300

1,042.79

312,837

9 July 2020

220

1,063.28

233,922

10 July 2020

200

1,061.03

212,206

Accumulated until now under the programme

466,152

985.54

459,412,788

Henceforth, Coloplast owns 3,288,667 treasury B shares of DKK 1 equal to 1.52% of the company’s total share capital.

An overview showing the transaction data for the period 6 – 10 July 2020 is enclosed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

For further information, please contact

Investors and analysts
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 / +45 4911 3376
Email: dkebj@coloplast.com

Rasmus Sørensen
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 1786
Email: dkraso@coloplast.com

Press and the media
Lina Danstrup
Sr. Media Relations Manager
Tel. +45 4911 2607
Email: dklina@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-07.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments